Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Applied logistic regression

(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305

The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725

Users' Guides to the Medical Literature

Jaeschke, R. (1994) · JAMA · doi:10.1001/jama.271.9.703 · Cited by 2,688

AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES

Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639

Biochemical detection of left-ventricular systolic dysfunction

McDonagh, T., Robb, S., Murdoch, D. R., Morton, J. J., Ford, I., Morrison, C., Tunstall‐Pedoe, H., McMurray, J. J. V., & Dargie, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03034-1 · Cited by 949

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

Cowie, M., Struthers, A. D., Wood, D. A., Coats, A. J. S., Thompson, S. G., Poole-Wilson, P. A., & Sutton, G. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06031-5 · Cited by 869

Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction

Omland, T., Aakvaag, A., Bonarjee, V., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 698

Meta-analysis of Pap Test Accuracy

Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 690

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

McDonagh, T. A., Morrison, C., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J. J. V., & Dargie, H. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03033-x · Cited by 628

Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy

Yamamoto, K., Burnett, J. C. J., Jougasaki, M., Nishimura, R. A., Bailey, K. R., Saito, Y., Nakao, K., & Redfield, M. M. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.988 · Cited by 518

Impact of age and sex on plasma natriuretic peptide levels in healthy adults

Wang, T. J., Larson, M. G., Levy, D. A., Leip, E. P., Benjamin, E. J., Wilson, P. W. F., Sutherland, P. A., Omland, T., & Vasan, R. S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02464-5 · Cited by 471

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction

Maisel, A. S., Koon, J., Krishnaswamy, P., Kazenegra, R., Clopton, P., Gardetto, N. J., Morrisey, R., Garcia, A., Chiu, A., & DeMaria, A. N. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113215 · Cited by 377

Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function

Fouad, F. M., Słomiński, J. M., & Tarazi, R. C. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80289-2 · Cited by 352

When can a risk factor be used as a worthwhile screening test?

Wald, N., Hackshaw, A., & Frost, C. D. (1999) · BMJ · doi:10.1136/bmj.319.7224.1562 · Cited by 342

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction

Lerman, A., Gibbons, R. J., Rodeheffer, R. J., Bailey, K. R., McKinley, L. J., Heublein, D. M., & Burnett, J. C. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)93125-k · Cited by 313

Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality : the case of stress echocardiography

Asada, J., & 渡邊, 潤. (2003) · Medical Entomology and Zoology · Cited by 251

Echocardiographic assessment of left ventricular hypertrophy

Reichek, N. (1982) · European Heart Journal · doi:10.1093/eurheartj/3.suppl_a.49 · Cited by 233

Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction

Davidson, N. C., Naas, A. A., Hanson, J., Kennedy, N. S. J., Coutie, W. J., & Struthers, A. D. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89176-x · Cited by 183

Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population

Luchner, A., Burnett, J. C. J., Jougasaki, M., Hense, H. W., Heid, I. M., Muders, F., Riegger, G. N. A. J., & Schunkert, H. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018080-00018 · Cited by 177

Percentage of Shortening of the Echocardiographic Left Ventricular Dimension

Quiñones, M. A., Pickering, E., & Alexander, J. K. (1978) · CHEST Journal · doi:10.1378/chest.74.1.59 · Cited by 152

Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?

McMurray, J. J. V., McDonagh, T., Davie, A. P., Cleland, J. G. F., Francis, C. M., & Morrison, C. E. (1998) · European Heart Journal · doi:10.1093/eurheartj/19.6.842 · Cited by 151

Ruling Out or Ruling In Disease with the Most sensitiue or Specific Diagnostic Test

Boyko, E. J. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400210 · Cited by 124

Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study

Luchner, A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00510-7 · Cited by 116

Clinical criteria and biochemical markers for the detection of systolic dysfunction

Yamamoto, K., Burnett, J. C. J., Bermudez, E. A., Jougasaki, M., Bailey, K. R., & Redfield, M. M. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.9676 · Cited by 116

Enhancing and Evaluating Diagnostic Accuracy

Swets, J. A., Getty, D. J., Pickett, R. M., D’Orsi, C. J., Seltzer, S. E., & McNeil, B. J. (1991) · Medical Decision Making · doi:10.1177/0272989x9101100102 · Cited by 116

Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study

Smith, H. E. (2000) · BMJ · doi:10.1136/bmj.320.7239.906 · Cited by 97

Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care

McClure, S. J., Caruana, L., Davie, A. P., GOLDTHORP, S. L., & McMurray, J. J. V. (1998) · BMJ · doi:10.1136/bmj.317.7157.516 · Cited by 85

Predictive properties of serum prostate-specific antigen testing in a community setting.

Jacobsen, S. J., Bergstralh, E. J., Guess, H. A., Katusic, S. K., Klee, G. G., Oesterling, J. E., & Lieber, M. M. (1996) · PubMed · doi:10.1001/archinte.157.15.1765b · Cited by 66

Section 34 : some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements

Cupples, L. A. (1987) · Medical Entomology and Zoology · Cited by 64

Limited Echocardiography for Hypertensive Left Ventricular Hypertrophy

Sheps, S. G., & Frohlich, E. D. (1997) · Hypertension · doi:10.1161/01.hyp.29.2.560 · Cited by 51

Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population The Tromsø Study

Schirmer, H. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1396 · Cited by 43

Simplified Echocardiography in the Diagnosis of Heart Failure

Willenheimer, R. B., Israelsson, B. A., Cline, C. M. J., & Erhardt, L. (1997) · Scandinavian Cardiovascular Journal · doi:10.3109/14017439709058063 · Cited by 38

Prevalence-Value-Accuracy Plots: A New Method for Comparing Diagnostic Tests Based on Misclassification Costs

Remaley, A. T., Sampson, M. L., DeLeo, J. M., Remaley, N. A., Farsi, B. D., & ZWEIG, M. H. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.934 · Cited by 30

Screening for Cardiac Dysfunction in Asymptomatic Patients by Measuring B-type Natriuretic Peptide Levels.

Suzuki, T., Yamaoki, K., NAKAJIMA, O., Yamazaki, T., Yamada, Y., Akioka, H., Yazaki, Y., & Nagai, R. (2000) · Japanese Heart Journal · doi:10.1536/jhj.41.205 · Cited by 25

Untitled work

Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4

Untitled work

(1950) · doi:10.1002/1097-0142(1950)3:1

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,137

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,739

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304

Burden of Systolic and Diastolic Ventricular Dysfunction in the Community

Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989

Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction

Goetze, J. P., Møgelvang, R., Maage, L., Scharling, H., Schnohr, P., Søgaard, P., Rehfeld, J. F., & Jensen, J. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl406 · Cited by 94

Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study

de Lemos, J. A., McGuire, D. K., Khera, A., Das, S. R., Murphy, S. A., Omland, T., & Drazner, M. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.017 · Cited by 103

Identification of Previously Undiagnosed Left Ventricular Systolic Dysfunction: Community Screening Using Natriuretic Peptides and Electrocardiography

Ng, L. L., Loke, I. W., Davies, J. E., Khunti, K., Stone, M. A., Abrams, K. R., Chin, D. T., & Squire, I. B. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00154-5 · Cited by 54

Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides

Ng, L. L., Loke, I. W., Davies, J. E., Geeranavar, S., Khunti, K. K., Stone, M. A., Chin, D. T., & Squire, I. B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.058 · Cited by 92

Abstract 18079: B-Type Natriuretic Peptide is a Screening Tool to Rule Out Subclinical Left Ventricular Geometry and Diastolic Dysfunction in a Community-Based Population

Hasegawa, T., Asakura, M., Kanzaki, H., Kim, J., Asanuma, H., Funada, A., Sugano, Y., Ohara, T., Anzai, T., & Kitakaze, M. (2013) · Circulation · doi:10.1161/circ.128.suppl_22.a18079